Metropolitan Life Insurance CO Standard Biotools Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

38 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.6 - $3.99 $8,942 - $22,300	-5,589 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$2.8 - $3.96 $15,649 - $22,132	5,589 New	5,589 $20,000
Q1 2022 Mar 30, 2023	SELL	$2.8 - $3.96 $43,464 - $61,471	-15,523 Reduced 73.53%	5,589 $20,000
Q1 2022 May 12, 2022	SELL	$2.8 - $3.96 $43,464 - $61,471	-15,523 Reduced 73.53%	5,589 $20,000
Q4 2021 Jun 21, 2023	BUY	$3.63 - $6.13 $76,636 - $129,416	21,112 New	21,112 $82,000
Q4 2021 Mar 30, 2023	BUY	$3.63 - $6.13 $14,193 - $23,968	3,910 Added 22.73%	21,112 $82,000
Q4 2021 Feb 15, 2022	BUY	$3.63 - $6.13 $14,193 - $23,968	3,910 Added 22.73%	21,112 $83,000
Q3 2021 Jun 21, 2023	BUY	$5.5 - $7.41 $94,611 - $127,466	17,202 New	17,202 $113,000
Q3 2021 Mar 30, 2023	SELL	$5.5 - $7.41 $37,966 - $51,151	-6,903 Reduced 28.64%	17,202 $113,000
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $37,966 - $51,151	-6,903 Reduced 28.64%	17,202 $113,000
Q2 2021 Jun 21, 2023	BUY	$4.35 - $6.35 $104,856 - $153,066	24,105 New	24,105 $148,000
Q2 2021 Mar 30, 2023	BUY	$4.35 - $6.35 $13,841 - $20,205	3,182 Added 15.21%	24,105 $148,000
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $104,765 - $152,933	24,084 Added 114685.71%	24,105 $148,000
Q1 2021 Jun 26, 2023	BUY	$3.94 - $7.09 $82,436 - $148,344	20,923 New	20,923 $94.6 Million
Q1 2021 Mar 30, 2023	BUY	$3.94 - $7.09 $28,427 - $51,154	7,215 Added 52.63%	20,923 $94,000
Q1 2021 May 14, 2021	SELL	$3.94 - $7.09 $53,926 - $97,040	-13,687 Reduced 99.85%	21 $95,000
Q4 2020 Jun 22, 2023	BUY	$5.45 - $8.65 $74,708 - $118,574	13,708 New	13,708 $82,000
Q4 2020 Mar 30, 2023	SELL	$5.45 - $8.65 $20,295 - $32,212	-3,724 Reduced 21.36%	13,708 $82,000
Q4 2020 Feb 16, 2021	SELL	$5.45 - $8.65 $20,295 - $32,212	-3,724 Reduced 21.36%	13,708 $82,000
Q3 2020 Jun 26, 2023	BUY	$4.34 - $11.43 $75,654 - $199,247	17,432 New	17,432 $129,000
Q3 2020 Mar 30, 2023	SELL	$4.34 - $11.43 $31,803 - $83,759	-7,328 Reduced 29.6%	17,432 $129,000
Q3 2020 Nov 13, 2020	SELL	$4.34 - $11.43 $31,803 - $83,759	-7,328 Reduced 29.6%	17,432 $130,000
Q2 2020 Jun 26, 2023	BUY	$1.85 - $5.29 $45,806 - $130,980	24,760 New	24,760 $99,000
Q2 2020 Mar 30, 2023	BUY	$1.85 - $5.29 $2,340 - $6,691	1,265 Added 5.38%	24,760 $99,000
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $45,806 - $130,980	24,760 New	24,760 $99,000
Q1 2020 Jul 12, 2023	BUY	$1.24 - $4.35 $6,858 - $24,059	5,531 New	5,531 $14 Million
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $54,038 - $120,294	-23,495 Closed	0 $0
Q3 2019 Jul 12, 2023	BUY	$4.63 - $12.15 $108,781 - $285,464	23,495 New	23,495 $108,000
Q3 2019 Mar 30, 2023	BUY	$4.63 - $12.15 $55,930 - $146,772	12,080 Added 105.83%	23,495 $108,000
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $55,930 - $146,772	12,080 Added 105.83%	23,495 $109,000
Q2 2019 Jul 12, 2023	BUY	$11.49 - $14.17 $163,525 - $201,667	14,232 New	14,232 $175,000
Q1 2019 Jul 13, 2023	BUY	$8.47 - $14.36 $96,685 - $163,919	11,415 New	11,415 $151,000
Q1 2019 Mar 30, 2023	BUY	$8.47 - $14.36 $96,685 - $163,919	11,415 New	11,415 $151,000
Q1 2019 May 16, 2019	BUY	$8.47 - $14.36 $59,247 - $100,448	6,995 Added 158.26%	11,415 $151,000
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $37,437 - $63,471	4,420 New	4,420 $317,000
Q2 2018 Aug 15, 2018	SELL	$4.86 - $6.24 $67,918 - $87,204	-13,975 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $30,452 - $42,209	5,296 Added 61.02%	13,975 $0
Q4 2017 Feb 15, 2018	BUY	$4.46 - $6.45 $38,708 - $55,979	8,679	8,679 $51,000

Others Institutions Holding LAB

# of Institutions

143

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account